Crossmark

β-Blockers in COPD

Crossref DOI link: https://doi.org/10.1016/j.chest.2018.01.008

Published Print: 2018-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Maltais, François

Buhl, Roland

Koch, Andrea

Amatto, Valeria C.

Reid, Jim

Grönke, Lars

Bothner, Ulrich

Voß, Florian

McGarvey, Lorcan

Ferguson, Gary T.
Funding

Funding for this research was provided by:

Roche

Bayer

Northern Ireland Chest Heart and Stroke

Actelion Pharmaceuticals

GlaxoSmithKline

Chiesi Farmaceutici (NC3Rs)

Boehringer Ingelheim

British Heart Foundation

Novartis

Asthma UK
License Information

Text and Data Mining valid from 2018-06-01

Text and Data Mining valid from 2018-06-01

Version of Record valid from 2018-01-19
More Information

This article is maintained by: Elsevier

Article Title: β-Blockers in COPD

Journal Title: Chest

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.chest.2018.01.008

Content Type: article

Copyright: © 2018 The Authors. Published by Elsevier Inc under license from the American College of Chest Physicians.